Skip to main content

Policy/Advocacy

With opioid overdose deaths and stimulant use on the rise, FDA director Janet Woodcock highlighted for Rx Summit attendees several of the administration’s top initiatives to meet the challenge.
U.S. Rep. David Trone discussed the merger of his Freshmen Working Group on Addiction with the Bipartisan Opioid Task Force on Thursday at the Rx Summit. Rep. Lori Trahan, meanwhile, said she is reintroducing legislation to standardize SUD training for prescribers.
Today’s addiction crisis is not the same as those that preceded it, and while there are reasons for concern, CDC director Rochelle Walensky, MD, MPH, told Rx Drug Abuse & Heroin Summit attendees in a session presented Wednesday morning that she also sees reasons for hope.
U.S. Rep. Hal Rogers told Rx Summit attendees on Tuesday that PDMPs are a great defense against the nation’s opioid threat, but concerns remain in a number of areas, including the future of Purdue Pharma. Sen. Mitch McConnell and Rep. Tom Cole, meanwhile, said the pandemic has heightened the need to double down in the opioid addiction fight.
Acknowledging that addiction is a crisis that “touches families in every community in red states and blue states, across all races and creeds,” President Joe Biden told Rx Drug Abuse & Heroin Summit attendees in prepared remarks presented on Monday that his administration will face the challenge head-on.
Back to Top